Patient Empowerment Program: A Rare Disease Podcast cover art

Patient Empowerment Program: A Rare Disease Podcast

Patient Empowerment Program: A Rare Disease Podcast

By: n-Lorem Foundation (Dr. Stan Crooke Amy Williford Kim Butler Andrew Serrano Jon Magnuson and Kira Dineen)
Listen for free

Join the nano-rare disease community! Interviews features leading physicians, scientists, biotech experts, and patient advocates. Lessons teach core concepts about drugs. Our host Dr. Crooke has led the creation of antisense technology and his foundation, n-Lorem, is using this powerful technology to discover, develop, and provide personalized experimental antisense oligonucleotide medicines to nano-rare patients for free, for life. n-Lorem is a non-profit organization established to apply the efficiency, versatility and specificity of antisense technology to charitably provide experimental antisense oligonucleotide (ASO) medicines to treat patients (less than 30 patients) that are the result of a single genetic defect unique to only one or very few individuals. The advantage of experimental ASO medicines is that they can be developed rapidly, inexpensively and are highly specific. n-Lorem was founded by Dr. Stan Crooke, who founded IONIS Pharmaceuticals in 1989 and, through his vision and leadership, established the company as the leader in RNA-targeted therapeutics. The podcast is produced by n-Lorem Foundation and hosted by Dr. Stanley T. Crroke, who is the Founder, CEO and Chairman. Our videographer is Jon Magnuson. Our producers are Kira Dineen, Jon Magnuson, Kim Butler, and Amy Williford. To learn more about n-Lorem, visit nlorem.org. Contact us at podcast@nlorem.org.Copyright 2024 n-Lorem Foundation Biological Sciences Hygiene & Healthy Living Physical Illness & Disease Science
Episodes
  • The Personal Rare Disease Journey Behind CNBC Cures with Becky Quick
    Jul 1 2026

    We’re celebrating our 100th episode with a special guest, CNBC Squawk Box’s own Becky Quick! Becky’s daughter Kaylie lives with SYNGAP1, and their family’s rare disease experience inspired the creation of CNBC Cures, an initiative bringing together families, doctors, investors and regulators with one goal in mind: helping to raise awareness of, and improve patient outcomes for, the 30 million Americans suffering from rare diseases. Get to know Becky and her daughter Kaylie’s story in this episode of the n-lorem Patient Empowerment Program podcast.

    Sign up for the CNBC Cures Newsletter: https://www.cnbc.com/cnbc-cures-newsletter/

    On this episode we discuss:

    1:25 – Celebrating 100 episodes of the n-Lorem Patient Empowerment Program podcast

    6:40 – Welcome Becky Quick; CNBC Anchor and mother of a Kaylie

    10:35 – Becky’s journalistic origins and path

    16:13 – Launching CNBC Cures and the need to help others facing rare diseases

    23:00 – Navigating life with the challenges caused by rare disease

    29:03 – Kaylie’s SYNGAP1 diagnostic odyssey

    42:10 – Tending with the loss of control

    43:56 – Non-verbal does not mean lacking understanding

    48:30 – SYNGAP1 explained

    59:01 – Hope is powerful

    -----

    Make hope possible with a donation in support of nano-rare patient programs: https://www.nlorem.org/donate/

    This episode is made possible thanks to our sponsors: Learn more about Chemgenes - https://www.chemgenes.com/

    Show More Show Less
    1 hr and 10 mins
  • Patient Story: Understanding ALS with Bill O'Sullivan and Neil Shneider, M.D., Ph.D.
    Jun 17 2026

    In this episode of the n-Lorem Patient Empowerment Program Podcast, Dr. Stan Crooke is joined by n-Lorem patient Bill O’Sullivan and Dr. Neil Shneider to discuss Bill’s experience living with a rare inherited form of ALS caused by a CHCHD10 mutation. Bill shares his path to diagnosis, the impact of genetic testing, and his experience receiving a personalized antisense oligonucleotide (ASO) treatment designed to target the underlying cause of his disease. Together, they discuss how advances in genetics and precision medicine are creating new possibilities for patients and families affected by rare neurodegenerative diseases.

    On this episode we discuss:

    • 00:00 Introduction
    • 00:58 Meet Bill O’Sullivan and Dr. Neil Shneider
    • 03:17 Family history and inherited ALS
    • 06:37 Diagnosis and discovery of CHCHD10
    • 10:02 Early symptoms and diagnostic challenges
    • 20:20 Beginning personalized ASO treatment
    • 22:33 Treatment results and disease stabilization
    • 23:42 Looking ahead: earlier intervention and future generations
    • 27:57 Expanding treatment opportunities through genetic research

    Links:

    This episode is made possible thanks to our sponsor ChemGenes

    Donate to n-Lorem and Make Hope Possible

    Register to attend the 2026 Nano-rare Patient Colloquium

    Show More Show Less
    53 mins
  • Miracles of Science #3: RNA World Part 3
    Jun 3 2026

    In this episode of the n-Lorem Patient Empowerment Program Podcast, host Stan Crooke explores the fascinating world of RNA biology and explains how different types of RNA work together inside cells. He breaks down the roles of ribosomal RNA, messenger RNA, transfer RNA, and several regulatory and processing RNAs, showing how they help convert genetic information into proteins and control cellular function. The episode also highlights how advances in RNA science are helping the n-Lorem Foundation develop individualized treatments for nano-rare patients and their families.

    • 0:00 – Introduction to the mission of n-Lorem and hope for nano-rare patients and families.
    • 0:51 – Stan Crooke introduces the podcast and explains n-Lorem’s groundbreaking treatment model.
    • 1:12 – Overview of the RNA world and why different RNA types are essential to biology.
    • 1:48 – Introduction to translational RNAs and their role in making proteins.
    • 2:16 – Explanation of ribosomes and how they translate genetic code into proteins.
    • 5:12 – Discussion of pre-ribosomal RNA processing and the role of the nucleolus.
    • 7:48 – Ribosomes are compared to the Enigma machine for decoding biological information.
    • 9:29 – Overview of transfer RNAs (tRNAs), codons, and amino acid delivery.
    • 12:23 – Why decoding the genetic code was a landmark scientific breakthrough.
    • 14:18 – How tRNAs mature through RNA processing and splicing mechanisms.
    • 16:03 – Summary of how mRNA, rRNA, and tRNA work together during translation.
    • 18:37 – Introduction to processing RNAs and spliceosome machinery.
    • 21:15 – Explanation of U4 RNA and its role in RNA quality control and disease.
    • 23:00 – Overview of snoRNAs and their role in ribosomal RNA maturation.
    • 24:06 – Discussion of Cajal body RNAs and RNA modification systems.
    • 25:01 – Introduction to regulatory non-coding RNAs and antisense RNAs.
    • 27:50 – Overview of circular RNAs and their potential regulatory functions.
    • 28:51 – Explanation of microRNAs and how they regulate protein production.
    • 29:59 – Closing thoughts on regulatory RNAs and cellular control systems.
    Show More Show Less
    36 mins
adbl_web_anon_alc_button_suppression_t1
No reviews yet